NmVac4-A/C/Y/W-135
Vaccine against bacterial meningitis / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about NmVac4-A/C/Y/W-135?
Summarize this article for a 10 year old
NmVac4-A/C/Y/W-135 is the commercial name of the polysaccharide vaccine against the bacterium (specifically serogroups A, C, Y, and W-135) that causes meningococcal meningitis. The product, by JN-International Medical Corporation, is designed and formulated to be used in developing countries for protecting populations during meningitis disease epidemics.
Vaccine description | |
---|---|
Target | Neisseria meningitidis A,C,Y,W-135 |
Vaccine type | Polysaccharide |
Clinical data | |
Routes of administration | Intramuscular(IM) |
ATC code | |
Identifiers | |
ChemSpider |
|
NY (what is this?) (verify) |
Meningococcal meningitis is a bacterial infection caused by the bacterium Neisseria meningitidis, also known as meningococcus. The vaccine is made from bacterial capsular polysaccharides through fermentation of each individual serogroup of Neisseria meningitidis in bioreactors. After fermentation, the polysaccharides are purified, formulated, and lyophilized using preservatives and stabilizers to make a vaccine product. The vaccine cannot protect from other serogroups of N. meningitidis and cannot eliminate the chance of infection by these serogroups.